Beta Pharma Canada Inc.
Records under this name other than patents Beta Pharma Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Beta Pharma Canada Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,404,736 | Heterocyclic amide derivatives as EP4 receptor antagonists Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,458,162 | Cyclic molecules as bruton's tyrosine kinase inhibitors Formerly held Lapsed on the fee record Ended Oct 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2024 | From the USPTO record |
| US 9,226,923 | Spirocyclic molecules as protein kinase inhibitors Formerly held Lapsed on the fee record Ended Jan 5, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 5, 2024 | From the USPTO record |
| US 9,345,905 | Heterocyclic amides compounds which are HDAC6 inhibitors and used as anti-tumoral agents Formerly held Lapsed on the fee record Ended May 24, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2020 | From the USPTO record |
| US 8,946,445 | Heterocyclic molecules as apoptosis inducers Formerly held Lapsed on the fee record Ended Feb 3, 2019 · From the USPTO record | Lapsed on the fee record | Ended Feb 3, 2019 | From the USPTO record |
| US 8,937,088 | Ureas for the treatment and prevention of cancer Lapsed on the fee record Ended Jan 20, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 20, 2019 | From the USPTO record |